# Sources — Mahalia Jackson

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 4, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Whitman A. “Mahalia Jackson, Gospel Singer, And a Civil Rights Symbol, Dies.” *The New York Times*, January 28, 1972 (On This Day archive). Supports her birth in New Orleans on October 26, 1911, as the third of six children of a longshoreman, barber and clergyman; that she was left motherless at six and raised by Aunt Duke; that she left school in the eighth grade to work as a cook and washerwoman; the move to Chicago in 1928 and the Greater Salem Baptist Church; that she never learned to read music; the Carnegie Hall debut on October 4, 1950, and tours abroad from 1952; the March on Washington; the bullet fired through a window of her South Side home; that “Since 1964 Miss Jackson was in and out of hospitals” and physicians warned her of exhaustion; hospitalization “in the fall of 1967 for heart trouble and again last fall”; the tours of Japan, India and Europe in 1971; and her death “of a heart seizure” at Little Company of Mary Hospital in Evergreen Park, Illinois, at 60. https://archive.nytimes.com/www.nytimes.com/learning/general/onthisday/bday/1026.html
2. Nixon R. “Statement on the Death of Mahalia Jackson,” January 27, 1972. The American Presidency Project. The editorial note supports her death at 60 “after a prolonged illness” at Little Company of Mary Hospital. https://www.presidency.ucsb.edu/documents/statement-the-death-mahalia-jackson
3. PBS. “Mahalia Jackson,” *This Far by Faith*. Gives the move to Chicago as 1927 and her death “of heart failure.” https://www.pbs.org/thisfarbyfaith/popup/3_mahalia_jackson.html
4. TheWrap. “Mahalia: 4 Key Facts About Mahalia Jackson’s Life the Lifetime Movie Missed,” April 2021. Supports a hysterectomy after touring London and Europe, the diagnosis of sarcoidosis, a year of recovery with a 50-pound weight loss, the tour cut short in 1968 with cramps in her legs and hands and inflammation in her eyes, the practice of being paid in cash, and death “in recovery after surgery to remove a bowel obstruction caused by sarcoidosis.” https://www.thewrap.com/mahalia-jackson-lifetime-biopic-key-facts-missed/
5. Wikipedia. “Mahalia Jackson.” Used for the health history it attributes to Laurraine Goreau’s *Just Mahalia, Baby* and to her autobiography: breathlessness during and after performances and abdominal cramping on the first European tour in 1952, the hysterectomy with granulomas and the diagnosis of sarcoidosis; occasional fatigue and breathlessness afterwards; in 1964 a coughing spell, a self-admission to a Chicago hospital, a public diagnosis of heart strain and exhaustion and a private account from her doctors of a heart attack and “sarcoidosis was now in her heart”; a year of recovery and a 50-pound weight loss; later fatigue, tachycardia and high blood pressure; touring of 200 dates a year in the Jim Crow South; illness in Germany in 1971; and death in recovery after bowel obstruction surgery in January 1972. Also her birth name, Mahala. https://en.wikipedia.org/wiki/Mahalia_Jackson
6. Biography.com. “Mahalia Jackson” (updated April 5, 2021). Supports several hospitalizations in her later years, the final concert in Munich in 1971, and death “of a heart attack.” https://www.biography.com/musicians/a52954124/mahalia-jackson
7. HISTMED Master Roster v3. Internal project source. Its entries were provisional and were not treated as independent corroboration.
8. New Orleans Historical (University of New Orleans). “Mahalia Jackson Theater for the Performing Arts.” Supports her collapse on tour in Munich in 1971 and gives her death as “of heart complications in her home in Chicago.” https://neworleanshistorical.org/items/show/977

## Clinical guidance

1. Crouser ED, et al. “Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline.” *Am J Respir Crit Care Med* 2020;201(8):e26–e51 (PMID 32293205). Diagnosis by a compatible presentation, non-necrotizing granulomas and exclusion of alternatives; EBUS-guided sampling rather than mediastinoscopy; baseline serum calcium (the one strong recommendation), ECG, eye examination, creatinine and alkaline phosphatase; cardiac MRI for suspected cardiac involvement. https://pubmed.ncbi.nlm.nih.gov/32293205/
2. Baughman RP, et al. “ERS clinical practice guidelines on treatment of sarcoidosis.” *Eur Respir J* 2021;58(6):2004079 (PMID 34140301). Glucocorticoids for symptomatic pulmonary disease with impaired function and for cardiac sarcoidosis, with methotrexate as the preferred steroid-sparing agent. https://pubmed.ncbi.nlm.nih.gov/34140301/
3. Birnie DH, et al. “HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.” *Heart Rhythm* 2014;11(7):1305–1323 (PMID 24819193). Diagnostic criteria; screening with ECG and further imaging when abnormal; FDG-PET for active inflammation; an electrophysiology study for a left ventricular ejection fraction above 35 percent with other risk markers, and a defibrillator if sustained ventricular arrhythmia is induced. https://pubmed.ncbi.nlm.nih.gov/24819193/
4. Cheng RK, et al. “Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.” *Circulation* 2024;149(21):e1197–e1216 (PMID 38634276). The current update to the 2014 consensus on imaging, immunosuppression and device decisions. https://pubmed.ncbi.nlm.nih.gov/38634276/
5. Humphrey MB, et al. “2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.” *Arthritis Rheumatol* 2023;75(12):2088–2102 (PMID 37845798). Fracture risk assessment with FRAX adjusted for glucocorticoid dose, and an oral bisphosphonate for adults at moderate risk. https://pubmed.ncbi.nlm.nih.gov/37845798/
6. Singh JA, et al. “2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs.” *Arthritis Care Res* 2012;64(5):625–639 (PMID 22473917). Methotrexate laboratory monitoring: blood count, liver tests and creatinine every two to four weeks for the first three months, then every eight to twelve weeks. https://pubmed.ncbi.nlm.nih.gov/22473917/
7. Equity: Baughman RP, et al. “Sarcoidosis in America. Analysis Based on Health Care Use.” *Ann Am Thorac Soc* 2016;13(8):1244–1252 (PMID 27509154): incidence and prevalence higher in African Americans, women twice as likely to have sarcoidosis, and the highest prevalence in African American women (178.5 per 100,000). Mirsaeidi M, et al. “Racial difference in sarcoidosis mortality in the United States.” *Chest* 2015;147(2):438–449 (PMID 25188873): age-adjusted mortality twelve times higher in African Americans, who died younger. https://pubmed.ncbi.nlm.nih.gov/27509154/ and https://pubmed.ncbi.nlm.nih.gov/25188873/
8. Stachler RJ, et al. “Clinical Practice Guideline: Hoarseness (Dysphonia) (Update).” *Otolaryngol Head Neck Surg* 2018;158(1 suppl):S1–S42 (PMID 29494321). Used at the sick visit: no routine antibiotics or steroids for acute laryngitis, and laryngoscopy when hoarseness lasts more than four weeks. https://pubmed.ncbi.nlm.nih.gov/29494321/
9. CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (Aether Forge, 2026): DXA and FRAX on chronic glucocorticoids, calcium and vitamin D handling, and repeat DXA every one to three years on therapy. https://patrickrutledge.github.io/topthirty/
10. Centers for Disease Control and Prevention. Adult Immunization Schedule by Medical Condition and Other Indication. https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html
11. U.S. Preventive Services Task Force: breast cancer (2024), colorectal cancer (2021), cervical cancer (2018), prediabetes and type 2 diabetes (2021), statin use (2022), depression (2023), intimate partner violence (2018), and the A and B recommendations; Medicare Preventive Services reference (Aether Forge, 2026). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations and https://patrickrutledge.github.io/preventative_services/

The CMID has no sarcoidosis monograph, so the specialty guidelines above govern the sarcoidosis and cardiac monitoring.

## Editorial resolutions

- **Recent-death rule.** She died in 1972, so the rule does not apply. The claims are still limited to what the fetched sources state. The Library of Congress, the Historic New Orleans Collection and the Mahalia Jackson Foundation pages, and the biographies by Laurraine Goreau and by Darden, were not read directly; the health history from Goreau is taken from Wikipedia’s summary, with TheWrap as a second source where it agrees, and is graded **D** with certainty “probable.”
- **When sarcoidosis was diagnosed.** The assignment described a diagnosis “reportedly in 1964.” The sources put the first diagnosis earlier: after the 1952 European tour, when a hysterectomy found granulomas (CLM-0005; Wikipedia and TheWrap). The 1964 admission is when, by Goreau’s account, her doctors told her privately of a heart attack and that “sarcoidosis was now in her heart” (CLM-0006). The modern episode therefore makes the first tissue diagnosis in a patient told years before that she had sarcoidosis, with no records, and finds cardiac involvement; this reconciles the two accounts.
- **Index age and dates.** The synthetic date of birth is October 26, 1973 (shift 62 years). The index visit on February 9, 2026 maps to February 9, 1964, when she was 52, in the year of the documented cardiac admission. All visits map to February to October 1964, within her lifetime; they are not a claim about where she was. The 1964 admission has no month in the sources, so its timeline event is dated “1964 to 1965” (it began a year of recovery) and its claims do not appear in the intake documents, which show only the 1952 history and earlier events.
- **Cause of death and cardiac sarcoidosis (R).** The sources disagree on the cause of death: a heart seizure (The New York Times), heart failure (PBS), a heart attack (Biography.com), heart complications at home (New Orleans Historical, which also conflicts on the place), and death in recovery after surgery for a bowel obstruction that TheWrap attributes to sarcoidosis (CLM-0011, disputed). That her heart disease was cardiac sarcoidosis rests on her biographer’s account of what her doctors told her in private and is recorded as a retrospective interpretation (CLM-0012, possible). The modern cardiac diagnosis is linked to both and resolves neither.
- **Later symptoms.** The eye inflammation and the cramps in her legs and hands by the late 1960s (CLM-0008) are recorded as stated; that the eye inflammation was sarcoid uveitis is not claimed. Her later high blood pressure and the diabetes that some sources mention are not claimed: the high blood pressure postdates the index date, and no fetched source documents diabetes.
- **Weight and diet.** Wikipedia records that she gained weight on tour and lost about 50 pounds during the year after 1964; TheWrap records the 50-pound loss. The modern record measures her weight and BMI (about 32) at each visit as any record would, without a weight-related diagnosis or comment on her body, and discusses diet only for steroid-related glucose and blood pressure. This is a deliberate choice to avoid stigma.
- **Presenting problems.** Exertional breathlessness and cough with hilar adenopathy (R06.09) is resolved at the consultation on February 23, 2026, when pulmonary sarcoidosis with lymph node involvement (D86.2, both_with_link) is recorded after EBUS. Palpitations with conduction disease (R00.2) is resolved on March 9, 2026, when cardiac sarcoidosis (D86.85, both_with_link) is recorded. Hypercalcemia (E83.52) resolves on treatment at the May visit. The intake documents state only what was known then.
- **Synthetic clinical picture.** All visits, results, imaging, pathology, the cardiac findings, the electrophysiology study and defibrillator, the regimen (prednisone 40 mg tapered to 7.5 mg; methotrexate 15 then 20 mg weekly), her height (170 cm) and weights are synthetic. Qualitative results (stains, cultures, lavage, interferon-gamma release assay, HIV and hepatitis tests, Holter, echocardiogram, MRI, PET, device checks, rapid viral tests) are in note and procedure text only.
- **Defibrillator.** An ICD was chosen for an ejection fraction of 47 percent with scar, nonsustained ventricular tachycardia and inducible sustained ventricular tachycardia, a Class IIa indication in the HRS consensus; dual chamber because of the conduction disease. This is a clinical judgment call for review, and the advance care planning records her wishes about deactivation.
- **Methotrexate and pneumocystis.** Atovaquone was chosen for pneumocystis prophylaxis instead of trimethoprim-sulfamethoxazole because of the interaction with methotrexate; prophylaxis stopped when prednisone fell below 20 mg. Judgment call for review.
- **Calcium and vitamin D.** Calcium supplements were stopped and avoided because of granuloma-driven hypercalcemia, bone protection used alendronate, and vitamin D was replaced at 1000 units daily only after calcium was normal, with calcium rechecked.
- **Sick visit.** Acute viral laryngitis on prednisone and methotrexate (J04.0), chosen because it is common, matters greatly to a singer, interacts with immunosuppression (no thrush, no fever, viral tests negative, treatment continued), and insinuates no undocumented real diagnosis. A concert was postponed with a promoter letter that gives no medical details.
- **Preventive visit.** A periodic adult preventive visit at 52 (CPT 99396 and 99497 in plain text): influenza and COVID-19 vaccines; PCV20, two recombinant zoster doses and the two-dose hepatitis B series already complete; mammogram ordered; colonoscopy up to date; cervical screening not indicated because examination showed no cervix after the documented hysterectomy (a synthetic finding; the extent of her real operation is not known); prediabetes with a diabetes prevention program offered; lipids without a statin; and advance care planning with an unnamed agent, including defibrillator deactivation.
- **Focused visits.** The four chronic-care follow-ups (the consultation, the cardiac diagnosis and start of treatment, nine weeks, and about six months) are documented as focused visits on the ATS 2020, ERS 2021, HRS 2014, AHA 2024, ACR glucocorticoid-induced osteoporosis and ACR methotrexate guidance, the CMID osteoporosis monograph and the CDC schedule. Synthetic findings introduced: cardiac sarcoidosis (D86.85), long-term glucocorticoid use (Z79.52), and the defibrillator (Z95.810). One protocol deviation is recorded instead of an invented result: the methotrexate blood tests due two to four weeks after starting were not done because no order was placed for the long gap between visits; no harm, since the nine-week results were normal; corrective action: standing orders every four weeks to twelve weeks, then every eight to twelve weeks, at a laboratory near home or on tour.
- **HRS 2023 update.** The assignment mentioned a 2023 HRS update; no 2023 HRS cardiac sarcoidosis statement was found on PubMed. The 2024 AHA scientific statement is cited as the current update instead.
- **Consultation.** The pulmonology referral and the consultation by Kwabena Asante-Miller, MD (a fictional consultant), on February 23, 2026, are **S**. The consultant answers the six referral questions in line with what the record shows afterwards: sarcoidosis confirmed by EBUS with infection excluded; organ screening and calcium handling; Holter, echocardiogram, MRI and FDG-PET before treatment (all done, showing cardiac sarcoidosis); prednisone with methotrexate; an electrophysiology study and a dual-chamber defibrillator (placed after inducible ventricular tachycardia); and the monitoring and touring plan. His advice on methotrexate blood tests every two to four weeks was not followed at first, as the nine-week visit records.
- **Aliases and names.** Her birth name, Mahala Jackson, is the only alias; “Jackson” alone is not used as an alias. Dr. Martin Luther King Jr. appears only in a claim. Her husbands, her aunt, her pianist and other associates are not named in the modern episode or given any role; her health care agent is unnamed. No other figure with a record in the dataset is named; her performances at events connected with such figures are left out for that reason.
- **Not used.** Accounts of her marriages beyond the obituary’s facts, and details of her final illness and surgery beyond CLM-0009 to CLM-0011, are not used. Her real habits (tobacco, alcohol, diet) were not researched.
